IP Library Granted Patent US 8,423,113
Granted Patent B2
US 8,423,113 · App. 12/258,335 · Granted Apr 16, 2013

Systems and methods for processing sensor data

Inventors: Mohammad Ali Shariati (Del Mar, CA); Apurv Ullas Kamath (San Diego, CA); J. Michael Dobbles (San Clemente, CA); Aarthi Mahalingam (San Diego, CA)
Assignee: DexCom, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,423,113
App. No.
12/258,335
Granted
Apr 16, 2013
Kind
B2
Abstract

Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.

Claims (17)

1. A method for providing a diabetes therapy instruction based on a noise classification in a signal obtained from a continuous glucose sensor, the method comprising:

receiving a signal from a continuous glucose sensor, the signal indicative of a glucose concentration in a host;

classifying a level of noise on the signal, using a processor module, into one of at least three groups, wherein criteria for classification into each of the three groups are different; and

providing, dependent upon the group into which the noise is classified, at least one of a diabetes therapy instruction, an alarm indicative of hypoglycemia, an alarm indicative of hyperglycemia, an alarm indicative of predicted hypoglycemia, or an alarm indicative of predicted hyperglycemia.

2. The method of claim 1 , wherein the providing comprises providing a diabetes therapy instruction.

3. The method of claim 2 , wherein the providing a diabetes therapy instruction comprises providing a more conservative diabetes therapy recommendation when the level of noise on the signal is classified into one of the three groups as compared to a less conservative diabetes therapy recommendation when the level of noise on the signal is classified into a different one of the three groups.

4. The method of claim 2 , wherein the providing a diabetes therapy instruction comprises providing an instruction to request a user interaction in a closed loop delivery system when the level of noise on the signal is classified into one of the three groups but not when the level of noise on the signal is classified into a different one of the three groups.

5. The method of claim 2 , wherein the diabetes therapy instruction comprises instructions for controlling insulin delivery.

6. The method of claim 2 , further comprising displaying a representation of the signal indicative of a glucose concentration on a user interface, wherein the representation depends upon the group into which the level of noise on the signal is classified.

7. The method of claim 2 , wherein the at least three groups comprise a first group associated with a light level of noise, a second group associated with a medium level of noise and a third group associated with a heavy level of noise.

8. The method of claim 2 , wherein the at least three groups are each associated with a different level of confidence in the signal.

9. The method of claim 2 , wherein the at least three groups are each associated with a different level of reliability of the signal.

10. The method of claim 1 , wherein the providing comprises providing at least one of an alarm indicative of hypoglycemia, an alarm indicative of hyperglycemia, an alarm indicative of predicted hypoglycemia, or an alarm indicative of predicted hyperglycemia.

11. The method of claim 10 , further comprising displaying a representation of the signal indicative of a glucose concentration on a user interface, wherein the representation depends upon the group into which the level of noise on the signal is classified.

12. The method of claim 10 , wherein the at least three groups comprise a first group associated with a light level of noise, a second group associated with a medium level of noise and a third group associated with a heavy level of noise.

13. The method of claim 10 , wherein the at least three groups are each associated with a different level of confidence in the signal.

14. The method of claim 10 , wherein the at least three groups are each associated with a different level of reliability of the signal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2009
From: SHARIATI, MOHAMMAD ALI; KAMATH, APURV ULLAS; DOBBLES, J. MICHAEL; MAHALINGAM, AARTHI
To: DEXCOM, INC.
Reel/Frame 023098/0981 →
Continuity (18)
Continuation In Part 11762638 · Jun 13, 2007
Continuation In Part 11498410 · Aug 2, 2006
Continuation In Part 10648849 · Aug 22, 2003
Continuation In Part 11007920 · Dec 8, 2004
Continuation In Part 11077739 · Mar 10, 2005
Continuation In Part 11750907 · May 18, 2007
Continuation In Part 11675063 · Feb 14, 2007
Continuation In Part 11404417 · Apr 14, 2006
Continuation In Part 10896639 · Jul 21, 2004
Continuation In Part 11404417 · Apr 14, 2006
Provisional Application 60528382 · Dec 9, 2003
Provisional Application 60587787 · Jul 13, 2004
Provisional Application 60587800 · Jul 13, 2004
Provisional Application 61614683 · Sep 30, 2004
Provisional Application 60614764 · Sep 30, 2004
Provisional Application 60490009 · Jul 25, 2003
Provisional Application 61014398 · Dec 17, 2007
Related Publication 20090192380A1 · Jul 30, 2009